• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体传播的探索性研究:奥密克戎是最主要的变体。

An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.

作者信息

Rathinasamy Muthusami, Kandhasamy Saritha

机构信息

Department of Computer Applications, Dr. Mahalingam College of Engineering and Technology, Pollachi, Tamil Nadu, India.

Department of Mathematics, P. A. College of Engineering and Technology, Pollachi, Tamil Nadu, India.

出版信息

J Med Virol. 2022 Jun;94(6):2414-2421. doi: 10.1002/jmv.27634. Epub 2022 Feb 26.

DOI:10.1002/jmv.27634
PMID:35112734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9015234/
Abstract

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, it accumulates mutations, which are changes in the genetic code. Because this virus has built-in RNA repair mechanisms, it generates mutations more slowly than some other RNA viruses. Thousands of mutations have emerged since the beginning of the pandemic throughout all virus genomes sequenced to date, resulting in thousands of distinct variants. However, some variants have recently been discovered that appear to increase transmissibility and may affect illness pervasiveness. In this study, we investigated SARS-CoV-2 variants and how countries intervene with them. We also depicted the top 25 countries where the Omicron variant is prevalent, with the UK, US, Denmark, France, and Australia having the top five places as of January 13, 2022. The perception of SARS-CoV-2 variants was investigated in those five countries, and the propagation rate of the Omicron variant was determined to be 51%, 29%, 26%, 15%, and 44%, respectively, indicating that the Omicron variant is the most prevalent among the others. Then, a study of SARS-CoV-2 infection test rate based on tests conducted per one million populations with a number of sequences in those five countries reveals that 25%, 73%, 1.6%, 4.8%, and 1.5%, respectively, it suggests that viral testing should be increased in all five countries since it will help to determine the precise distribution of variants and aid governments in making policy decisions for public safety. We anticipated the production of new variants strains. This study implies that limiting disease transmissions, such as acquiring a coronavirus disease 2019 vaccine and booster doses for those aged 18 and older, as well as wearing the mask in public places, is the best strategy to prevent the emergence of new variants.

摘要

随着严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的进化,它会积累突变,即遗传密码的改变。由于这种病毒具有内置的RNA修复机制,它产生突变的速度比其他一些RNA病毒要慢。自疫情开始以来,在所有已测序的病毒基因组中出现了数千种突变,产生了数千种不同的变体。然而,最近发现一些变体似乎增加了传播性,并可能影响疾病的普遍程度。在本研究中,我们调查了SARS-CoV-2变体以及各国如何对其进行干预。我们还描绘了奥密克戎变体流行的前25个国家,截至2022年1月13日,英国、美国、丹麦、法国和澳大利亚位列前五。我们在这五个国家调查了对SARS-CoV-2变体的认知情况,确定奥密克戎变体的传播率分别为51%、29%、26%、15%和44%,这表明奥密克戎变体在其他变体中最为流行。然后,根据这五个国家每百万人口进行的检测数量以及检测序列数量对SARS-CoV-2感染检测率进行的一项研究表明,其感染检测率分别为25%、73%、1.6%、4.8%和1.5%,这表明这五个国家都应增加病毒检测,因为这将有助于确定变体的精确分布,并协助政府做出公共安全政策决策。我们预计会产生新的变异毒株。这项研究表明,限制疾病传播,如为18岁及以上人群接种2019冠状病毒病疫苗和加强针,以及在公共场所佩戴口罩,是预防新变体出现的最佳策略。

相似文献

1
An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.一项关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体传播的探索性研究:奥密克戎是最主要的变体。
J Med Virol. 2022 Jun;94(6):2414-2421. doi: 10.1002/jmv.27634. Epub 2022 Feb 26.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.一项针对 SARS-CoV-2 及其不同国家变异株奥密克戎的全基因组研究、突变筛查、系统进化和统计学分析。
J Infect Public Health. 2022 Aug;15(8):878-891. doi: 10.1016/j.jiph.2022.07.002. Epub 2022 Jul 8.
4
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
5
Is Omicron the last SARS-CoV-2 Variant of Concern?奥密克戎是否是最后一个令人关注的 SARS-CoV-2 变体?
Arch Med Res. 2022 Apr;53(3):336-338. doi: 10.1016/j.arcmed.2022.01.001. Epub 2022 Jan 19.
6
A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.新冠病毒奥密克戎变异株在印度中部第三次新冠疫情大流行期间的初步基因组分析。
Arch Med Res. 2022 Sep;53(6):574-584. doi: 10.1016/j.arcmed.2022.08.006. Epub 2022 Aug 23.
7
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
8
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.
9
Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.受体结合基序靶向 Sanger 测序:一种用于 SARS-CoV-2 变体分子监测的快速且具有成本效益的策略。
Microbiol Spectr. 2022 Jun 29;10(3):e0066522. doi: 10.1128/spectrum.00665-22. Epub 2022 May 31.
10
Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.2021 年初全球 COVID-19 大流行期间,低和高疫苗接种率国家中 SARS-CoV-2 变体的单倍型分布。
Infect Genet Evol. 2022 Jan;97:105164. doi: 10.1016/j.meegid.2021.105164. Epub 2021 Nov 27.

引用本文的文献

1
Analysis of COVID-19 reinfection and its influencing factors among primary healthcare workers in Jiangsu Province: a study based on the omicron variant epidemic.江苏省基层医护人员新冠病毒再感染情况及其影响因素分析:一项基于奥密克戎变异株流行情况的研究
Front Public Health. 2025 Jun 2;13:1521658. doi: 10.3389/fpubh.2025.1521658. eCollection 2025.
2
The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.中国南方某医院医护人员中奥密克戎 SARS-CoV-2 再感染的症状和间隔:一项横断面研究。
BMC Infect Dis. 2024 Mar 27;24(1):354. doi: 10.1186/s12879-024-09221-3.
3
Highly-specific aptamer targeting SARS-CoV-2 S1 protein screened on an automatic integrated microfluidic system for COVID-19 diagnosis.基于自动化集成微流控系统筛选针对 SARS-CoV-2 S1 蛋白的高特异性适体用于 COVID-19 诊断。
Anal Chim Acta. 2023 Sep 15;1274:341531. doi: 10.1016/j.aca.2023.341531. Epub 2023 Jun 21.
4
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.不同国家 SARS-CoV-2 感染人群中奥密克戎变异株的相对流行率:系统评价。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2212568. doi: 10.1080/21645515.2023.2212568.
5
SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus.严重急性呼吸综合征冠状病毒2:对抗和消除新型冠状病毒肺炎病毒的候选疫苗分析
Vaccines (Basel). 2022 Dec 7;10(12):2086. doi: 10.3390/vaccines10122086.
6
The Performance of Lateral Flow Tests in the Age of the Omicron: A Rapid Systematic Review.奥密克戎时代侧向流动检测的性能:一项快速系统评价
Life (Basel). 2022 Nov 21;12(11):1941. doi: 10.3390/life12111941.
7
Omicron variant: Current insights and future directions.奥密克戎变异株:当前的认识和未来方向。
Microbiol Res. 2022 Dec;265:127204. doi: 10.1016/j.micres.2022.127204. Epub 2022 Sep 17.
8
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.对新出现的奥密克戎(B.1.1.529)变体的突变情况进行全面分析,并与 VOCs 和 VOIs 的突变进行比较。
Geroscience. 2022 Oct;44(5):2393-2425. doi: 10.1007/s11357-022-00631-2. Epub 2022 Aug 22.
9
In-Person Schooling Amidst Children's COVID-19 Vaccination: Exploring Parental Perceptions Just after Omicron Variant Announcement.儿童新冠疫苗接种背景下的线下学校教育:在奥密克戎变种宣布后即刻探究家长的看法
Vaccines (Basel). 2022 May 12;10(5):768. doi: 10.3390/vaccines10050768.
10
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update.奥密克戎变异株流行背景下需要加强疫苗接种以应对 SARS-CoV-2 变异株的出现和 COVID-19 病例增加:更新。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2065824. doi: 10.1080/21645515.2022.2065824. Epub 2022 May 20.

本文引用的文献

1
SARS-CoV-2 Omicron variant: Characteristics and prevention.严重急性呼吸综合征冠状病毒2型奥密克戎变异株:特征与预防
MedComm (2020). 2021 Dec 16;2(4):838-845. doi: 10.1002/mco2.110. eCollection 2021 Dec.
2
OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear.奥密克戎(B.1.1.529):一种引起全球恐慌的新型关注变异株。
J Med Virol. 2022 May;94(5):1821-1824. doi: 10.1002/jmv.27541. Epub 2021 Dec 30.
3
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体:刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
4
The challenges of COVID-19 Delta variant: Prevention and vaccine development.新冠病毒德尔塔变异株的挑战:预防与疫苗研发
MedComm (2020). 2021 Oct 19;2(4):846-854. doi: 10.1002/mco2.95. eCollection 2021 Dec.
5
Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.新型关注变异株 SARS-CoV-2 奥密克戎(B.1.1.529)的特征及其全球视角。
J Med Virol. 2022 Apr;94(4):1738-1744. doi: 10.1002/jmv.27524. Epub 2022 Jan 11.
6
Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.南非出现的 SARS-CoV-2 变异株奥密克戎的序列分析。
J Med Virol. 2022 Apr;94(4):1728-1733. doi: 10.1002/jmv.27516. Epub 2021 Dec 27.
7
Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts - What is known so far?高度变异的新冠病毒奥密克戎毒株引发全球专家高度关注——目前已知情况如何?
Travel Med Infect Dis. 2022 Jan-Feb;45:102234. doi: 10.1016/j.tmaid.2021.102234. Epub 2021 Dec 8.
8
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.新冠疫情:科学家担心,奥密克戎毒株可能比其他变种更具传播性,且对现有疫苗有部分抗性。
BMJ. 2021 Nov 29;375:n2943. doi: 10.1136/bmj.n2943.
9
Analysis of the Delta Variant B.1.617.2 COVID-19.新冠病毒Delta变异株B.1.617.2的分析
Clin Pract. 2021 Oct 21;11(4):778-784. doi: 10.3390/clinpract11040093.
10
Australia's struggle with the delta variant.澳大利亚应对德尔塔变种毒株的艰难历程。
Lancet Infect Dis. 2021 Oct;21(10):1358. doi: 10.1016/S1473-3099(21)00579-X.